Boosting antibiotics performance by new formulations with deep eutectic solvents

• Autor(a) principal: Pedro, Sónia N.
• Data de Publicação: 2022
• Outros Autores: Gomes, Ana T. P. C., Oskoei, Párástu, Oliveira, Helena, Almeida, Adelaide, Freire, Mara G., Silvestre, Armando J. D., Freire, Carmen S. R.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10773/36058
• topic: Ciprofloxacin; Humans; Microbial Sensitivity Tests; Solvents; Staphylococcus aureus; Anti-Bacterial Agents; Deep Eutectic Solvents

The critical scenario of antimicrobial resistance to antibiotics highlights the need for improved therapeutics and/or formulations. Herein, we demonstrate that deep eutectic solvents (DES) formulations are very promising to remarkably improve the solubility, stability and therapeutic efficacy of antibiotics, such as ciprofloxacin. DES aqueous solutions enhance the solubility of ciprofloxacin up to 430-fold while extending the antibiotic stability. The developed formulations can improve, by 2 to 4-fold, the susceptibility of Gram-negative (Escherichia coli and Pseudomonas aeruginosa) and Gram-positive (Staphylococcus aureus) bacteria to the antibiotic. They also improve the therapeutic efficacy at concentrations where bacteria present resistance, without promoting tolerance development to ciprofloxacin. Furthermore, the incorporation of DES decreases the toxicity of ciprofloxacin towards immortalized human epidermal keratinocytes (HaCat cells). The results herein reveal the pioneering use of DES in fluoroquinolone-based formulations and their impact on the antibiotic's characteristics and on its therapeutic action.